We are hiring!
Paraza Pharma, Inc. is growing and looking for smart, passionate people to join our team. Multiple positions are available in our Chemical Sciences department. Please follow the link below to learn how to join our dynamic team!
News
News
|
April 8, 2025
As part of our 2025 Paraza Lecture Series, we wish to welcome Dr. David Sarlah, Rice University, on April 17th, 2025.
Seminar Title: Empowering Organic Synthesis: From Unique Methods to Complex Natural Products.
News
|
March 26, 2025
Paraza Pharma will be exhibiting at the AACR Annual Meeting 2025 taking place April 25-30, 2025, at the McCormick Place Convention Center, Chicago, IL. Come meet us at Booth# 341.
News
|
February 10, 2025
Paraza Pharma is happy to announce a joint publication with Epics Therapeutics entitled “Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.” J. Med. Chem. 2025, ASAP.
News
|
November 28, 2024
Montreal, QC – November 28, 2024 – Paraza Pharma, a leading contract research organization (CRO) specializing in end-to-end drug discovery services, is proud to announce the acquisition of adMare BioInnovations’ Analytical Services.
News
|
November 12, 2024
As part of our 2024 Paraza Lecture Series, we wish to welcome Dr. Corey Stephenson, University of British Columbia on November 25th, 2024.
Seminar Title: Redox Catalysis Strategies for Complex Molecules
News
|
October 7, 2024
Paraza is excited to announce that we will be attending the 36th EORTC-NCI-AACR conference at CCIB in Barcelona, Spain from Oct. 23rd to 25th, 2024. We look forward to seeing you at Booth 12.